Literature DB >> 14592705

Isoniazid resistance of exponentially growing Mycobacterium smegmatis biofilm culture.

Raymond Teng1, Thomas Dick.   

Abstract

Biofilm growth of Mycobacterium smegmatis was found to be unaffected at an isoniazid concentration that inhibited growth of planktonic bacilli (i.e. at isoniazid minimum inhibitory concentration=10 microg ml(-1)). Significant growth (50% of drug-free control) of biofilms was observed at up to 40 microg ml(-1) and the MIC for biofilm growth showed an increase to up to 80 microg ml(-1) isoniazid. Thus, the biofilm growth modus appears to be a strategy for replicating bacilli to evade the onslaught of antibacterials.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14592705     DOI: 10.1016/S0378-1097(03)00584-6

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  15 in total

1.  The trehalose-specific transporter LpqY-SugABC is required for antimicrobial and anti-biofilm activity of trehalose analogues in Mycobacterium smegmatis.

Authors:  Jeffrey M Wolber; Bailey L Urbanek; Lisa M Meints; Brent F Piligian; Irene C Lopez-Casillas; Kailey M Zochowski; Peter J Woodruff; Benjamin M Swarts
Journal:  Carbohydr Res       Date:  2017-08-09       Impact factor: 2.104

2.  Enzymatic hydrolysis of trehalose dimycolate releases free mycolic acids during mycobacterial growth in biofilms.

Authors:  Anil K Ojha; Xavier Trivelli; Yann Guerardel; Laurent Kremer; Graham F Hatfull
Journal:  J Biol Chem       Date:  2010-04-07       Impact factor: 5.157

3.  Identification of a small molecule with activity against drug-resistant and persistent tuberculosis.

Authors:  Feng Wang; Dhinakaran Sambandan; Rajkumar Halder; Jianing Wang; Sarah M Batt; Brian Weinrick; Insha Ahmad; Pengyu Yang; Yong Zhang; John Kim; Morad Hassani; Stanislav Huszar; Claudia Trefzer; Zhenkun Ma; Takushi Kaneko; Khisi E Mdluli; Scott Franzblau; Arnab K Chatterjee; Kai Johnsson; Kai Johnson; Katarina Mikusova; Gurdyal S Besra; Klaus Fütterer; Scott H Robbins; S Whitney Barnes; John R Walker; William R Jacobs; Peter G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-17       Impact factor: 11.205

Review 4.  Targeting drug tolerance in mycobacteria: a perspective from mycobacterial biofilms.

Authors:  Mohammad S Islam; Jacob P Richards; Anil K Ojha
Journal:  Expert Rev Anti Infect Ther       Date:  2012-09       Impact factor: 5.091

5.  Location of persisting mycobacteria in a Guinea pig model of tuberculosis revealed by r207910.

Authors:  Anne J Lenaerts; Donald Hoff; Sahar Aly; Stefan Ehlers; Koen Andries; Luis Cantarero; Ian M Orme; Randall J Basaraba
Journal:  Antimicrob Agents Chemother       Date:  2007-05-21       Impact factor: 5.191

Review 6.  NTM drug discovery: status, gaps and the way forward.

Authors:  Mu-Lu Wu; Dinah B Aziz; Véronique Dartois; Thomas Dick
Journal:  Drug Discov Today       Date:  2018-04-07       Impact factor: 7.851

7.  Keto-mycolic acid-dependent pellicle formation confers tolerance to drug-sensitive Mycobacterium tuberculosis.

Authors:  Dhinakaran Sambandan; Dee N Dao; Brian C Weinrick; Catherine Vilchèze; Sudagar S Gurcha; Anil Ojha; Laurent Kremer; Gurdyal S Besra; Graham F Hatfull; William R Jacobs
Journal:  mBio       Date:  2013-05-07       Impact factor: 7.867

8.  Why is long-term therapy required to cure tuberculosis?

Authors:  Lynn E Connolly; Paul H Edelstein; Lalita Ramakrishnan
Journal:  PLoS Med       Date:  2007-03       Impact factor: 11.069

9.  The role of iron in Mycobacterium smegmatis biofilm formation: the exochelin siderophore is essential in limiting iron conditions for biofilm formation but not for planktonic growth.

Authors:  Anil Ojha; Graham F Hatfull
Journal:  Mol Microbiol       Date:  2007-09-14       Impact factor: 3.501

10.  Biofilm development by potentially pathogenic non-pigmented rapidly growing mycobacteria.

Authors:  Jaime Esteban; Nieves Z Martín-de-Hijas; Teemu J Kinnari; Guillermo Ayala; Ricardo Fernández-Roblas; Ignacio Gadea
Journal:  BMC Microbiol       Date:  2008-10-17       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.